ConductScience.org, home

Paper42201051

Beyond the Scan: Adapting Multimodal Lung Cancer Screening for Central and Eastern Europe-Overcoming Systemic Barriers and Epidemiological Confounders.

Anghel R and 8 others. Med Sci (Basel), 2026. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Beyond the Scan: Adapting Multimodal Lung Cancer Screening for Central and Eastern Europe-Overcoming Systemic Barriers and Epidemiological Confounders. Papers, record 42201051. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42201051

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Beyond the Scan: Adapting Multimodal Lung Cancer Screening for Central and Eastern Europe-Overcoming Systemic Barriers and Epidemiological Confounders.
PubMed
Journal
Med Sci (Basel)
PubMed
Year
2026
PubMed
Publication types
Journal Article, Review, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-08-13
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Anghel RRodica
2Folea ARAntonia-Ruxandrahttps://orcid.org/0009-0000-3350-7850
3Moga VLVlad-Luca
4Pavel CCristian
5Troncotă DDiana
6Celea MMatei
7Dumitru COCorneliu-Octavian
8Șerban AIAndreea-Iren
9Bîlteanu LLiviu

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Lung NeoplasmsMajor topic
Early Detection of CancerMajor topic
Mass ScreeningMajor topic
Humans
Europe, Eastern
Hungary
Tomography, X-Ray Computed
Risk Factors

Source PubMed

Download CSV of topics

References262

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
121714641Reduced lung-cancer mortality with low-dose computed tomographic screening.N Engl J Med2011https://conductscience.org/library/papers/21714641PubMed
231817261Standard Expected Years of Life Lost Due to Malignant Neoplasms in Poland, 2000-2014.Int J Environ Res Public Health2019https://conductscience.org/library/papers/31817261PubMed
329641468Associations of Mediterranean Diet and a Posteriori Derived Dietary Patterns with Breast and Lung Cancer Risk: A Case-Control Study.Nutrients2018https://conductscience.org/library/papers/29641468PubMed
433215430Can life satisfaction be considered a predictor of quality of life in patients with lung cancer?Eur Rev Med Pharmacol Sci2020https://conductscience.org/library/papers/33215430PubMed
529801465
Erlotinib as single agent first line treatment in locally advanced or metastatic activating EGFR mutation-positive lung adenocarcinoma (CEETAC): an open-label, non-randomized, multicenter, phase IV clinical trial.
BMC Cancer2018https://conductscience.org/library/papers/29801465PubMed
635369633The effect of the RadioProtect cosmetic formulation on the skin of oncological patients treated with selected cytostatic drugs and ionizing radiation.Postepy Dermatol Alergol2022https://conductscience.org/library/papers/35369633PubMed
740943939EBUS-TBNA for Diagnosis and Staging of Lung Cancer: A Retrospective Regional Analysis Integrating Clinical and Molecular Data (EXPoSURE Score).J Clin Med2025https://conductscience.org/library/papers/40943939PubMed
841020868Serum TNF -α, IL-10 and IL-2 Trajectories and Outcomes in NSCLC and Melanoma Under Anti-PD-1 Therapy: Longitudinal Real-World Evidence from a Single Center.Curr Issues Mol Biol2025https://conductscience.org/library/papers/41020868PubMed
935601926Implementing Lung Cancer Screening in Europe: Taking a Systems Approach.JTO Clin Res Rep2022https://conductscience.org/library/papers/35601926PubMed
1027105879The Frequency of EGFR Mutation in Lung Adenocarcinoma and the Efficacy of Tyrosine Kinase Inhibitor Therapy in a Hungarian Cohort of Patients.Pathol Oncol Res2016https://conductscience.org/library/papers/27105879PubMed
1124501604High costs as a slow down factor of thoracoscopic lobectomy development in Poland - an institutional experience.Wideochir Inne Tech Maloinwazyjne2013https://conductscience.org/library/papers/24501604PubMed
1225884958Availability and outcomes of radiotherapy in Central Poland during the 2005-2012 period - an observational study.BMC Cancer2015https://conductscience.org/library/papers/25884958PubMed
1340724620Beyond Comorbidity: Pulmonary Adenocarcinoma in a Patient with Rheumatoid Arthritis-A Case Report and Literature Review.Life (Basel)2025https://conductscience.org/library/papers/40724620PubMed
1430510781A country wide adaptation of the European Society of Thoracic Surgeons lung cancer core database: the Hungarian model.J Thorac Dis2018https://conductscience.org/library/papers/30510781PubMed
1521303801European cancer mortality predictions for the year 2011.Ann Oncol2011https://conductscience.org/library/papers/21303801PubMed
1636277960
EGFR T790M Mutation Detection in Patients With Non-Small Cell Lung Cancer After First Line EGFR TKI Therapy: Summary of Results in a Three-Year Period and a Comparison of Commercially Available Detection Kits.
Pathol Oncol Res2022https://conductscience.org/library/papers/36277960PubMed
1739529341Evaluation of epidemiological and pathological features of symptomatic spinal metastases in Romania - what could we learn from a retrospective study?Rom J Morphol Embryol2024https://conductscience.org/library/papers/39529341PubMed
1839510703Lung Cancer in Romania.J Thorac Oncol2024https://conductscience.org/library/papers/39510703PubMed
1935410926Prevalence, symptom burden and under-diagnosis of chronic obstructive pulmonary disease in Polish lung cancer screening population: a cohort observational study.BMJ Open2022https://conductscience.org/library/papers/35410926PubMed
2023900869Morphological characteristics of potentially malignant pulmonary nodules in high-risk male smokers detected in lung cancer screening trial in Cracow, Poland.Pol J Pathol2013https://conductscience.org/library/papers/23900869PubMed

See all 262 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42201051

GET https://conductscience.org/api/papers/v1/42201051/references?page=2